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USING an ELISA technique, concentrations of T-interferon
and interleukin-2 were assayed in the supernatants of
colonic intraepithelial lymphocytes cultured with or
without phytohaemagglutinin (PHA). IntraepitheHal
lymphocytes produced low concentrations of T-inter-
feron and interleukin-2 when stimulated with PHA, but
significantly more than when unstimulated (p< 0.05).
There was no difference in production ofthese cytokines
by IEL from control or inflammatory bowel disease.
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Introduction
Intraepithelial lymphocytes (IEL) are found inter-
spersed between the epithelial cells of the
gastrointestinal tract and so bear a close spatial rela-
tionship to luminal antigens. The precise function of
IEL in the human is not known, although they may
have a role in the induction of gut tolerance to
luminal contents. 1,2
Cytokines are soluble factors released by immune
cells, especially macrophages and lymphocytes. One
hypothesis for the pathogenesis of ulcerative colitis
(UC) is that abnormal release of cytokines may result
in disordered immunoregulation. Murine IEL do not
spontaneously release interleukin-2 (IL-2) but do so
when stimulated.-5 A ,-interferon-like factor has also
been shown to be produced after stimulation with
mitogens.
Human small bowel IEL have been reported to
produce IL-2 in response to stimulation with
phytohaemagglutinin (PHA) and T-interferon (TIFN)
in response to PHA and sheep red blood cell (RBC)
lysates. However, no data are available concerning
cytokine production by human colonic IEL.
The aim of this study was to test the hypothesis
that abnormal amounts of IL-2 and ,IFN are pro-
duced by human colonic IEL in patients with UC.
Materials and Methods
Subjects: Normal mucosa, at least 5 cm from any
macroscopic lesion, from colonic resection speci-
mens was used from nine control patients (eight
carcinoma, one polyp; median age 68 years, range
38-81 years). The least inflamed segment of the
resected colon was used from six patients with UC
(median age 35 years, range 26-58 years). All the
patients with UC underwent colonic resection for
severe disease which was unresponsive to medical
treatment and so were taking corticosteroids at the
time of the study.
Isolation of mucosal lymphocytes: IEL were isolated
as described previously. 1,2,7,8 Briefly, following resec-
tion, the colonic specimens were washed with
Hanks’ Balanced Salt Solution (Flow Laboratories,
UK) without calcium and magnesium, and supple-
mented with gentamycin 50 t.tg/ml, penicillin 100 U/
ml and streptomycin 100 l.tg/ml (HBSS). The mucosa
was dissected and following further washing the
mucosal strips were incubated with RPMI supple-
mented with 10% foetal calf serum, antibiotics and
1 mM dithiothreitol (Sigma) for 10 min. The mucosal
strips were then washed a further three times in HBSS
and incubated with 0.75 mM EDTA in a shaking
water bath at 37C for three periods of 30 min each
at 140 oscillations per min. Following each incuba-
tion the supernatant containing the 1EL was pooled,
centrifuged at 500 xg for 8 min and the pellet
washed three times in RPMI. The cells were
resuspended in RPMI and stored overnight at 4C.
Further purification was achieved by passing this
crude preparation down a glass wool column
(Sigma) and performing a two-step Percoll gradient
of 44% and 67.5%. The IEL were recovered from the
interface.
Monoclonal antibodies: To detect T cell subsets, T
helper/suppressor test (CD4 FITC, CD8 PE),
LeucoGATE (HLe-1 FITC, Leu-M3 PE) and simultest
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control reagent (IgG1, FITC, IgG PE) were used. All
monoclonal antibodies were prepared by Becton
Dickinson Immunocytometry Systems (Mountain
View, CA, USA).
Immunofluorescence and FACS analysis:
Immunofluorescent staining was performed as de-
scribed previously. Briefly, cells were suspended in
PBS/0.1% sodium azide to a concentration of 106
cells/ml. Aliquots of 100 lal were incubated with 8
of monoclonal antibody in the dark at 4C for 45 min.
The cells were then washed with PBS, centrifuged
and resuspended in 500 btl PBS, paraformaldehyde
1%. Flow cytometric analysis was performed using a
FACScan (Becton Dickinson).
Preparation of lymphokine-containing supernatant:
IEL at a concentration of 1 x 106 were cultured in
l ml aliquots in 24-well plates (Linbro, Flow
Laboratories, UK) with or without 10 btg/ml PHA
(Wellcome Laboratories, Beckenham, UK) for 72 h at
37C and 5% CO2. The supernatants were then har-
vested, centrifuged and passed through a 0.22 btm
filter and stored at-20C until analysis was per-
formed.
Cytokine assays: 3,IFN was measured by an enzyme
amplified sensitivity immunoassay of proven
specificity (Medgenix Diagnostics, Belgium). IL-2
was measured by a sandwich enzyme immunoassay
of proven specificity (T Cell Sciences, Cambridge,
MA, USA). Optical densities were measured by an
automated dual beam ELISA reader (Titertek
Multiscan, Flow Laboratories, UK) at 450 nm for 3’IFN
and 490 nm for IL-2. Concentrations of the cytokines
were determined by reference to the serially diluted
standards included on each plate. The minimum
detectable concentrations of these assays were: 3’IFN,
0.03 U/ml; IL-2, 6 pg/0.1 ml. Recombinant human
3,IFN and IL-2 were used as positive controls.
Culture of HT29 for Class II induction: 3,IFN
induces Class II expression on the colonic cancer cell
line HT29 in a dose-dependent fashion. Serial
dilutions of supernatants from IEL cultured with
or without 10 l.tg/ml PHA were cultured with 1 x 106
HT29 cells (a generous gift of Dr. P. Brandtzaeg)
for 72 h in a 24-well plate at 37C in 5% CO2. The
HT29 cells were then stained with 10l.tl of
phycoerythrin anti-HLA DR monoclonal antibody
(Becton Dickinson, Mountain View, CA, USA) and
analysed by flow cytometry (FACScan, Becton
Dickinson).
Ethics: Ethics Committee approval for this study was
obtained from the Central Oxford Regional Ethics
Committee.
Statistics: The Mann-Whitney U and Spearman’s
Rank Correlation tests were used when appropriate.
p < 0.05 was taken as significant.
Results
Phenotypic characterization ofmucosal lymphocytes:
The IEL populations had a median CD4/CD8 ratio of
0.22 (controls, range 0.10-0.33) and 0.20 (UC, range
0.12-0.30).
Lymphokine production by PHA-stimulated colonic
IEL: The median concentration of 3,IFN secreted by
IEL alone (control vs. UC) was 0.3 U/ml (range 0-0.6)
and 0.5 U/ml (range 0-0.7) respectively (not signifi-
cant). Following stimulation with PHA the concentra-
tion in controls increased to 3.9 (range 0.9-26) and
in UC to 0.85 (range 0.3-10.1). These values were
significantly higher than for the unstimulated IEL
(p< 0.05, Fig. 1). The median concentration of IL-2
secreted by IEL alone (control vs. UC) was 1 U/ml
(range 0-20) and 0 U/ml (range 0-10) respectively
(not significant). Following stimulation with PHA the
concentration in controls increased to 15 U/ml
(range 0-30) and in UC to 5.5 U/ml (range 0-50).
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FIG. 1. y-interferon (’yIFN) concentrations (U/ml) secreted by unstimulated
IEL and IEL cultured with 10 lg/ml PHA from controls and ulcerative colitis.
,IFN production is significantly higher from IEL cultured with PHA
(p < 0.05). UC vs. controls, not significant. ,, UC; O, controls.
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FIG. 2. Interleukin 2 (IL-2) concentration (pg/ml) secreted by IEL from
controls and ulcerative colitis cultured with and without 10 g/ml PHA. IL-
2 production is significantly higher from IEL cultured with PHA (p < 0.05).
UC vs. controls, not significant. ,, UC; O, controls.
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These values were significantly higher than for the
unstimulated IEL (p < 0.05, Fig. 2).
Induction of HLA-DR molecules by culture
supernatant on HT29: Supernatants of unstimulated
IEL when incubated with HT29 cells produced no
detectable expression of HLA-DR molecules, as as-
sessed by flow cytometry. However, the supernatants
of stimulated control IEL produced 5% HLA-DR ex-
pression of HT29 (Fig. 3). This effect was also ob-
served using supernatants of stimulated IEL which
had been irradiated (2 500 Rad) prior to culture (data
not shown).
Discussion
Rat IEL produce a yIFN-like factor capable of pro-
ducing Ia expression on IEC 17 cells. Lymphocyte
proliferation was not essential for the production of
this factor. In mice, Con A stimulated IEL to produce
moderate levels of IFN. Human small intestinal IEL
have been reported to produce 7IFN after stimulation
with PHA.8 This production of 7IFN is increased
many times by the addition of sheep RBC lysates.
The present data show that colonic IEL produce
very low amounts of yIFN. Although there was a
significant increase in 7IFN production following
stimulation with PHA, the absolute amounts of yIFN
produced were persistently low. This is not due to
the failure of lectin binding.
1 The amount of yIFN
produced by stimulated IEL is of sufficient quantity
to induce Class II molecules on HT29 cells. Class II
bearing epithelial cells can in turn cause further
activation of IEL.n In contrast to a previous study on
cytokine production by lamina propria lymphocytes
there was no significant difference in yIFN produc-
tion by IEL between control and IBD patients.
12
Most animal studies have shown that IEL do not
produce IL-2. Human small bowel IEL produce simi-
lar amount of IL-2 to peripheral blood T cells follow-
ing stimulation with mitogen. These data confirm
the finding that human colonic IEL produce IL-2. In
addition we have shown that there is no difference
in IL-2 production by colonic IEL in control and UC
patients.
It has recently been proposed that helper T.
(CD4/) cells can be classified with relationship to
their cytokine production profile. 13 Thus, T. cells
which produce small amounts of IL-2 and yIFN but
large amounts of IL-4, IL-5 and IL-10 are classified as
Tu2 cells. Conversely, cells producing large quantities
of IL-2 and yIFN but little IL-4, IL-5 and IL-10 are
called TH1 cells.
Human CD8 clones have also been analysed in a
similar manner. Lepromin specific CD8 T suppressor
clones from patients with lepromatous leprosy pro-
duce IL-4 and little or no yIFN (Type 2 pattern of
lymphokine production). In contrast, alloreactive
HLA B27-specific human CD8 CTL clones produce
yIFN but no IL-4 (Type 1 lymphokine pattern). In
these experiments, suppression was IL-4 dependent
and not necessarily related to phenotype, as CD4
clones which secreted IL-4 also caused suppres-
sion.14,15
Human colonic IEL have recently been shown to
have potent suppressive properties on the prolifera-
tive responses of autologous LPL. 1,2 This effect was
found to be CD8-dependent, 78-independent and
mediated by a soluble factor. The data presented in
this paper indicate that IEL produce only small quan-
tities of yIFN and IL-2, which indicates that they
could have a Type 2 pattern of lymphokine produc-
tion. Were this to prove to be the case, it may explain
the potent down-regulatory properties of IEL, on the
basis of IL-4 and/or IL-10 secretion.
In conclusion, colonic IEL produce the cytokines
yIFN and IL-2, although in small amounts. There is
no significant difference in production of yIFN and
IL-2 in control and UC patients.
HLA-DR expression
FIG. 3. Flow cytometric analysis of the effect of mucosal lymphocyte
supernatants on HLA-DR expression by HT29 cells. (a), HT29 alone
(control); (b), HT29 +supernatant of unstimulated IEL; (c),
HT29 + supernatant of stimulated IEL.
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